Also, a lot of nicely founded adverse prognostic markers, like U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their destructive result in individuals addressed with VO. The one aspect that remained predictive of the shorter progression-free survival in this cohort of sufferers was TP53 aberrations.112 At last, the alternative BTK inhib